PJSC Farmak, a Ukrainian pharmaceutical manufacturer, in 2019 received a net profit of about UAH 1.056 billion, which almost coincides with the indicator of 2018 (UAH 1.05 billion), the company said in the information disclosure system of the National Securities and Stock Market Commission.
Earlier it was reported that the company’s assets for the year increased by 12.3%, to UAH 6.657 billion.
The company plans to pay UAH 100 million in dividends.
In 2018, Farmak increased its net profit by 25.16% compared to 2017, to UAH 1.05 billion.
Farmak is a manufacturer of medicines of the European level, a leader in the pharmaceutical market of Ukraine in terms of sales. It exports products to 20 countries. It is a member of the Manufacturers of Medications of Ukraine association.
According to the state register, the ultimate beneficial owner of PJSC Farmak is the head of the supervisory board, Filia Zhebrovska, who owns 80% of the company.
